The Food and Drug Administration has identified a Class I recall of reprocessed electrophysiology and ultrasound catheters by Medline Industries due to specific lots potentially containing small residual particles. The FDA said that all affected products should be destroyed after recall response actions are complete. The agency also identified a Class I recall of all Automated Impella Controllers by Abiomed () due to the potential of an internal software error when a patient experiences a period longer than 80 minutes with no residual pulsatility. The Abiomed recall involves updating use instructions and does not involve removing them from where they are used or sold. 
 
The FDA also issued an early alert for catheter introducer kits by Abiomed and Oscor due to a potential for introducer sheath leakage.

Headline
The Food and Drug Administration has issued an early alert for all heart pump controllers by Abiomed, which sent a correction notice to all customers with…
Headline
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy…
Headline
The Food and Drug Administration has identified a nationwide recall. Arrow International is recommending dialysis catheter kits containing Merit Medical 16F…
Headline
The Food and Drug Administration has issued an early alert for certain Streamline Airless System Hemodialysis Bloodlines and B3 Low Volume Bloodlines by B.…
Headline
Olympus has expanded a voluntary recall of its ViziShot 2 FLEX Needles due to complaints of device components ejecting or attaching during…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…